Fingerprint
Dive into the research topics of 'IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease
Stephen B Hanauer, William J Sandborn, Brian G Feagan, Christopher Gasink, Douglas Jacobstein, Bin Zou, Jewel Johanns, Omoniyi J Adedokun, Bruce E Sands, Paul Rutgeerts, Willem J S de Villiers, Jean-Frédéric Colombel, Subrata Ghosh
Research output: Contribution to journal › Article › peer-review
41
Citations
(Scopus)
494
Downloads
(Pure)